Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-blind randomized trial of Vistabel in healthy women with glabellar lines
2011-004636-66Phase 4Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by Akademiska sjukhuset. Primary endpoint: Course of muscle paralysis, denervation and reinnervation. Started Oct 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2011-004636-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004636-66.